Viveve (NASDAQ:VIVE)

Non-surgical treatment for post-partum laxity of the vaginal introitus

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Viveve (NASDAQ:VIVE) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About Viveve (NASDAQ:VIVE)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups

More

Our Clients